The Food and Drug Administration has approved the use of MDMA, known as Ecstasy, to treat post-traumatic stress disorder in trials.
The New York Times interviewed a man who participated in the trial, C.J. Hardin. He went through three tours in Afghanistan and Iraq and suffers from PTSD. He told the Times Ecstasy changed his life -- he once was a hermit and at times suicidal. but now he is working and attending college.
Researchers say they're hopeful, but people may become addicted to the drug. The FDA declined to comment to the Times.